Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Amphastar Pharmaceuticals (29A) vs. Competitors

2 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:29AAmphastar PharmaceuticalsEUR 25.27EUR 1.09B12.5515.71%Moderate SellUnlock the DE:29A analyst price target with TipRanks PremiumDE:29AUnlock the DE:29A top-analyst price target with TipRanks Premium
VTRSViatris$19.63$22.79B-37.0492.64%Moderate BuyUnlock the VTRS analyst price target with TipRanks PremiumDE:29A vs VTRSUnlock the VTRS top-analyst price target with TipRanks Premium
TEVATeva$39.23$46.55B92.3750.88%Strong BuyUnlock the TEVA analyst price target with TipRanks PremiumDE:29A vs TEVAUnlock the TEVA top-analyst price target with TipRanks Premium
ANIPANI Pharmaceuticals$68.55$1.57B13.23-12.70%Moderate BuyUnlock the ANIP analyst price target with TipRanks PremiumDE:29A vs ANIPUnlock the ANIP top-analyst price target with TipRanks Premium
AMRXAmneal Pharmaceuticals$21.12$7.45B49.1283.41%Strong BuyUnlock the AMRX analyst price target with TipRanks PremiumDE:29A vs AMRXUnlock the AMRX top-analyst price target with TipRanks Premium

Performance Comparison

-50%-25%0%25%50%75%100%125%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:29AAmphastar Pharmaceuticals25.273.7217.26%
VTRSViatris19.639.5394.34%
TEVATeva39.2313.2350.88%
ANIPANI Pharmaceuticals68.55-11.17-14.01%
AMRXAmneal Pharmaceuticals21.129.1776.74%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts